Purdue Pharma's upcoming sentencing will allow settlement money to flow

Opioids News

Purdue Pharma's upcoming sentencing will allow settlement money to flow
General NewsPain ManagementLegal Proceedings

A judge is expected to sentence OxyContin maker Purdue Pharma to forfeit $225 million to the U.S. government. The criminal sentence Tuesday will mark a major step toward the company finalizing a settlement of thousands of lawsuits it faces over the toll of opioids. The sentence is part of a 2020 deal to resolve federal criminal and civil probes.

Trump says he’s 'highly unlikely' to renew ceasefire with Iran ahead of peace talks in PakistanThe Afternoon Wire2 killed, 5 injured as planned fight between teens turns into deadly shooting at North Carolina parkWith no end in sight to their deployment, National Guard troops roam WashingtonFormer first daughter Chelsea Clinton completes Boston Marathon, Bill and Hillary meet her at finishBook bans and attempted bans remain at record highs, with 'Sold' topping the listTim Cook will step down as Apple CEO and hand reins over to the iPhone maker's hardware leaderHumanoid robots run a Chinese half-marathon alongside flesh-and-blood competitorsFatou, the world's oldest gorilla living in captivity, celebrates her 69th birthday at Berlin ZooWorking unseen to frame risk and ritual in a conflict-zone funeralSome American farmers bet on solar.

Then Trump changed the rulesTrump signs order to speed review of psychedelics, including the controversial drug ibogaineA small but growing movement wants you to put down your phone. But first read thisAI is a gold mine for spammers and scammers, but Google is using it as a tool to fight backA spiced nuts and seeds recipe from Linda McCartney's plant-based 'Family Kitchen' cookbookPope prays at Catholic shrine in Angola that was a center of African slave tradeSuben los precios del petróleo y las acciones en Wall Street ceden un poco Then Trump changed the rulesTrump signs order to speed review of psychedelics, including the controversial drug ibogaineA small but growing movement wants you to put down your phone. But first read thisAI is a gold mine for spammers and scammers, but Google is using it as a tool to fight backA spiced nuts and seeds recipe from Linda McCartney's plant-based 'Family Kitchen' cookbookPope prays at Catholic shrine in Angola that was a center of African slave tradeSuben los precios del petróleo y las acciones en Wall Street ceden un pocoProtesters who have lost love ones to the opioid crisis protest outside a courthouse in Boston, Aug. 2, 2019, where a judge heard arguments in a lawsuit against Purdue Pharma. A sign with some names of the Sackler family is displayed at the Metropolitan Museum of Art Jan. 17, 2019, in New York. Cheryl Juaire holds photos of her sons, both of whom died from overdoses, Sean Merrill, left, and Corey Merrill, after making a statement during a hearing in New York on March 10, 2022. Protesters who have lost love ones to the opioid crisis protest outside a courthouse in Boston, Aug. 2, 2019, where a judge heard arguments in a lawsuit against Purdue Pharma. Protesters who have lost love ones to the opioid crisis protest outside a courthouse in Boston, Aug. 2, 2019, where a judge heard arguments in a lawsuit against Purdue Pharma. A sign with some names of the Sackler family is displayed at the Metropolitan Museum of Art Jan. 17, 2019, in New York. A sign with some names of the Sackler family is displayed at the Metropolitan Museum of Art Jan. 17, 2019, in New York. Cheryl Juaire holds photos of her sons, both of whom died from overdoses, Sean Merrill, left, and Corey Merrill, after making a statement during a hearing in New York on March 10, 2022. Cheryl Juaire holds photos of her sons, both of whom died from overdoses, Sean Merrill, left, and Corey Merrill, after making a statement during a hearing in New York on March 10, 2022. A judge is expected to sentence OxyContin maker Purdue Pharma to forfeit $225 million to the Justice Department on Tuesday, clearing the way for the company to finalize a settlement of thousands of lawsuits it faces over its role in the opioid crisis. The penalty was agreed to in a 2020 pact to resolve federal civil and criminal probes it was facing. If the judge signs off, other penalties will not be collected in return for Purdue settling the other lawsuits.last year and could take effect May 1. It requires members of the Sackler family who own the company to pay up to $7 billion to state, local and Native American tribal governments, some individual victims and others.The Stamford, Connecticut-based company admitted that it did not have an effective program to keep its powerful prescription painkillers from being diverted to the black market, even though it told the U.S. Drug Enforcement Administration that it did. It also admitted that it paid doctors through a speakers program to prescribe the drugs and paid an electronic medical records company to send doctors information on patients that encouraged more opioid prescriptions. While Purdue produced only a fraction of the opioid pills that flooded the market in the 2000s, advocates have long seen aggressive sales of OxyContin as one of the touchstones of the crisis. At a 1996 event to rally Purdue’s sales force, Richard Sackler, then a top Purdue executive and later president of the company, called for a “blizzard of prescriptions.”While Purdue is expected to pay $225 million, the government agreed in the plea deal not to collect $5.3 billion in criminal forfeitures and fines and $2.8 billion in civil liabilities. Instead, portions of that money are considered part of the broader settlement — and the federal government will receive a small slice of that.The broader settlement calls for members of the Sackler family who own the company to contribute up to $7 billion over 15 years. Most of the money is to go to government entities to use to fight the opioid crisis. It’s among the largest in a series of settlements by drugmakers, wholesalers and pharmacies in recent years — and the only major one that includes payments for some individual victims or their survivors. Under the Purdue deal, members of the Sackler family would be shielded from lawsuits over opioids from those who agree to the payments. Purdue itself would cease to exist and be replaced by a new company, Knoa Pharma, which would operate for the public benefit and have a board appointed by the states. The reorganization is considered one of the most complicated ever. By the end of last year, Purdue had paid law firms and other professionals working on all sides of the case more than $1 billion, according to a court filing.Members of the Sackler family have long been cast as villains in the opioid crisis, seeking to increase profits even as it became clear people were becoming addicted to OxyContin and overdosing.Family members received $10.7 billion in payments from Purdue from 2008 to 2018. They have not been paid by the company since 2018 — and the last of them left Purdue’s board in 2019.More than 54,000 people with personal injury claims against Purdue voted to accept the settlement, and 218 voted against it. Still, some victims and their family members have been pushing back for years, asserting that the settlement and the guilty plea stop short of justice for victims of a crisis that has been linked to 900,000 deaths in the U.S. since 1999.Susan Ousterman’s son, Tyler Cordiero, died at age 24 in 2020 after overdosing on a mixture that included fentanyl after years of using heroin and other opioids. She organized others who lost loved ones to deliver victim impact statements to the court ahead of the sentencing. She said the aim was to persuade the judge to reject the plea deal and for the U.S. Justice Department to pursue criminal charges against individuals, including Sackler family members. “It shouldn’t be going to states and municipalities,” said Ousterman, noting some governments have not yet used the funds they’re received and others have used it in waysMulvihill covers topics on the agendas of state governments across the country. He has focused on abortion, gender issues and opioid litigation.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

AP /  🏆 728. in US

General News Pain Management Legal Proceedings Indictments CT State Wire New Jersey West Virginia KY State Wire Kentucky OH State Wire Connecticut WV State Wire TN State Wire Ohio Tennessee U.S. Department Of Justice Business Susan Ousterman Stamford Lawsuits U.S. News Richard Sackler Tyler Cordiero U.S. News

 

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Taking Root: Pelage Pharma's Hair Regrowth GambitTaking Root: Pelage Pharma's Hair Regrowth GambitPelage Pharmaceuticals enters late-stage trials with PP405, a topical gel that 'awakens' hair follicles. See why Google Ventures is betting on this startup.
Read more »

Jackson County Schools closed Friday to curb illness spreadJackson County Schools closed Friday to curb illness spreadThey will be closed on Friday to allow for a thorough cleaning, school officials say.
Read more »

2027 Linebacker and Purdue Target Sets Commitment DateA highly-coveted linebacker prospect in the 2027 class has set his commitment date. He is deciding between Indiana, Purdue, Kentucky and Louisville.
Read more »

Where Purdue Basketball Stands in Multiple Way-Too-Early Top 25 RankingsWhere Purdue Basketball Stands in Multiple Way-Too-Early Top 25 RankingsSeveral media outlets have released way-too-early rankings for the 2026-27 season. Where does Purdue stand in each of these rankings?
Read more »



Render Time: 2026-04-21 07:37:35